MoonLake Immunotherapeutics (MLTX) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ACLX, AKRO, AMLX, AVTE, CERE and others.
MLTX has a market capitalization of $1.35B, compared to an average peer market cap of $3.3B. MLTX is notably smaller than its average peer.
